SEC 13F Intelligence

XERIS BIOPHARMA HOLDINGS INC

CUSIP 98422EAB9

Xeris Biopharma Holdings Inc has 2 institutional holders in Filings Flow’s 13F database, together reporting 33.57M shares worth $69M as of Q1 2026. The largest reported holders are Capstone Investment Advisors, LLC, Polar Asset Management Partners Inc., and Deerfield Management Company, L.P..

Institutional Holders
2
Q1 2026
Reported Value
$69M
Ticker
unmapped
private placement or foreign
Quarters Tracked
2

Ownership Trend

Institutional holders
Q4 ’25: 2Q4 ’25Q1 ’26: 2Q1 ’26filingsflow.com
Total reported value
Q4 ’25: $89MQ4 ’25Q1 ’26: $69MQ1 ’26filingsflow.com

Holders

Mixed quarters
Manager% of PortfolioValueSharesQuarter
Polar Asset Management Partners Inc.$5.0B AUM0.43%$21M10.50MQ1 2026
DEERFIELD MANAGEMENT COMPANY, L.P.$8.5B AUM0.32%$18M10.50MQ2 2025OLDER
CAPSTONE INVESTMENT ADVISORS, LLC$57.4B AUM0.08%$47M23.07MQ1 2026

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.